Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) is a publicly traded Healthcare sector company. As of May 21, 2026, EPRX trades at $6.66 with a market cap of $437.04M and a P/E ratio of 0.00. EPRX moved +1.27% today. Year to date, EPRX is -17.06%; over the trailing twelve months it is +63.34%. Its 52-week range spans $2.20 to $9.32. Analyst consensus is strong buy with an average price target of $14.80. Rallies surfaces EPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own EPRX include Redmile Group. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Eupraxia Pharmaceuticals Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $6.66 |
| Market Cap | $437.04M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.32 |
| 52-Week Low | $2.20 |
| Volume | 23 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover EPRX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.80.